TCT23 Late-breakers: Full Schedule Announced
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26
Stay updated with breaking news from Roberta Byrne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26
MULTISTARS-AMI may be the first trial of its kind to show that operators and patients can safely choose either strategy and attain similar outcomes.
It’s too early to know if a device that uncouples itself with time, leaving behind a healthier, supple vessel, can fill an unmet need.
In patients with diabetes and left main artery disease, the risks for PCI and CABG are different when either can be used.
While both treatments had similar 5-year all-cause mortality in a meta-analysis, other endpoints made the case for nuance.